Clinical Trials
2 trialsNCT06492421 2024-07-09
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
Second Affiliated Hospital of Guangzhou Medical University
Phase 2 Recruiting
NCT06483347 2024-07-03
Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
Second Affiliated Hospital of Guangzhou Medical University
Phase 2 Recruiting